Drugs / PF-06293620
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02211261 | Sep 2014 → Jan 2017 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06293620 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02211261 ↗ |
| Route | Subcutaneous | “subcutaneous, single dose 0.3 mg/kg” NCT02211261 ↗ |